Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00181. Mole weight: Mw 100,000 Da. |  |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00182. Mole weight: Mw 150,000-400,000 Da. | |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00183. Mole weight: Mw 400,000 Da. | |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00184. Mole weight: Mw 600,000-1,100,000 Da. | |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00185. Mole weight: Mw 3,300,000-3,800,000 Da. | |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00186. Mole weight: Mw 4,300,000-4,800,000 Da. | |
| Poly(ethylene oxide) | PEO. CAS No. 25322-68-3. Product ID: 6-00187. Mole weight: Mw 7,200,000 Da. | |
| Poly(ethylene oxide) | Poly(ethylene oxide). Group: Poly(ethylene glycol) and poly(ethylene oxide)polymers. CAS No. 25322-68-3. |  |
| Poly(ethylene oxide), 4-arm, amine terminated | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). |  |
| Poly(ethylene oxide), 4-arm, amine terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Poly(ethylene oxide), 4-arm, carboxylic acid terminated | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 4-arm, carboxylic acid terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Poly(ethylene oxide), 4-arm, hydroxy terminated | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 4-arm, hydroxy terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Poly(ethylene oxide)4-armsuccinimid& | Poly(ethylene oxide)4-armsuccinimid&. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: POLY(ETHYLENE OXIDE)4-ARMSUCCINIMID&; peo-4 arm-sg terminated; Poly(ethylene oxide), 4-arm, succinimidyl glutarate terminated average Mn 10,000 by GPC. CAS No. 154467-38-6. 96%. | |
| Poly(ethylene oxide), 4-arm, succinimidyl glutarate terminated | average Mn 10,000 by GPC. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 4-arm, succinimidyl succinate terminated | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 4-arm, succinimidyl succinate terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Poly(ethylene oxide), 4-arm, thiol terminated | average Mn 10,000, contains >40 ppm DTT as stabilizer. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 4-arm, thiol terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Poly(ethylene oxide), 6-arm, anthracene terminated | average Mn ~10,000. Group: Photonic and optical materials. | |
| Poly(ethylene oxide), 6-arm, anthracene terminated | Poly(ethylene oxide), 6-arm, anthracene terminated. Group: other materials. | |
| Poly(ethylene oxide), 6-arm, hydroxy terminated | average Mn 17,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene oxide), 6-arm, hydroxy terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 17000. | |
| Poly(ethylene oxide), average Mn 3500 | Poly(ethylene oxide), average Mn 3500. Group: Polymers. CAS No. 25322-68-3. | |
| Poly(ethylene oxide)-block-polycaprolactone, 4-arm | PEG average Mn ~2,500. Group: Biodegradable polymers. | |
| Poly(ethylene oxide)-block-polycaprolactone, 4-arm | Poly(ethylene oxide)-block-polycaprolactone, 4-arm. Group: Biodegradable polymerspoly(ethylene glycol) and poly(ethylene oxide). CAS No. 30174-06-2. | |
| Poly(ethylene oxide)-block-polycarprola& | Poly(ethylene oxide)-block-polycarprola&. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2-oxepanone,polymerwithoxirane;POLY(ETHYLENE OXIDE)-BLOCK-POLYCARPROLA&;Poly(ethylene oxide)-block-polycaprolactone, four-arm. Product Category: Biomaterials. CAS No. 30174-06-2. Purity: 0.96. Product ID: ACM30174062. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Poly(ethylene oxide)-block-polylactide, 4-arm | poly(ethylene oxide) Mn ~2,500, PLA average Mn ~3,500. Group: Biodegradable polymers. | |
| Poly(ethylene oxide)-block-polylactide, 4-arm | We offer you this block copolymer with good biocompatibility. Group: Biodegradable polymerspoly(ethylene glycol) and poly(ethylene oxide). Pack Sizes: 250 mg in glass insert 1 g in glass bottle. Molecular formula: PLA average Mn ~3,500 poly(ethylene oxide) Mn ~2,500. | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01115. Molecular formula: HO-[CH2CH2O]n-H. Mole weight: available in Mw from 100-7,000 kDa. | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01622. Mole weight: Mw 200,000 Da. Properties: ~900 mPas (5%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01623. Mole weight: Mw 300,000 Da. Properties: ~13 Pas (2%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01624. Mole weight: Mw 900,000 Da. Properties: ~3 Pas (2%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01625. Mole weight: Mw 2,000,000 Da. Properties: ~3.6 Pas (1%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01626. Mole weight: Mw 4,000,000 Da. Properties: ~6.5 Pas (1%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01627. Mole weight: Mw 5,000,000 Da. Properties: ~8.75 Pas (1%). | |
| Poly(ethylene oxide) NF | PEO. Grades: NF. CAS No. 25322-68-3. Product ID: 8-01628. Mole weight: Mw 7,000,000 Da. Properties: 40-60 Pas. | |
| Dimethylsiloxane,ethylene oxide block copolymer | Dimethylsiloxane,ethylene oxide block copolymer. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DIMETHYLSILOXANE, ETHYLENE OXIDE BLOCK COPOLYMER;POLY(DIMETHYLSILOXANE-CO-ETHYLENE OXIDE), AB BLOCK COPOLYMER;POLY[DIMETHYLSILOXANE-CO-METHYL(3-HYDROXYPROPYL)SILOXANE]-GRAFT-POLY(ETHYLENE GLYCOL) METHYL ETHER;POLY(DIMETHYLSILOXANE-B-ETHYLENE OXIDE), METHY. Product Category: Bioelectronics. CAS No. 68938-54-5. Product ID: ACM68938545. Alfa Chemistry ISO 9001:2015 Certified. | |
| Epichlorohydrin/ethylene oxide copolymer | Epichlorohydrin/ethylene oxide copolymer. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (chloromethyl)-oxiranpolymerwithoxirane;Oxirane,(chloromethyl)-,polymerwithoxirane;EPICHLOROHYDRIN/ETHYLENE OXIDE COPOLYMER;POLY(EPICHLOROHYDRIN-CO-ETHYLENE OXIDE);EPICHLOROHYDRIN-ETHYLENE OXIDE POLYMER;ALPHA-Epichlorohydrin-ethylene oxide copolymer. Product Category: Polymer/Macromolecule. CAS No. 24969-10-6. Molecular formula: [CH(CH2Cl)CH2O]x(CH2CH2O)y. Mole weight: 136.576760 [g/mol]. Purity: 0.96. IUPACName: 2-(chloromethyl)oxirane; oxirane. Density: 1.4. Product ID: ACM24969106. Alfa Chemistry ISO 9001:2015 Certified. | |
| Poly(1-vinylpyrrolidone-co-vinyl acetate), average Mw ~50,000(GPC vs. poly(ethylene oxide)), powder | Poly(1-vinylpyrrolidone-co-vinyl acetate), average Mw ~50,000(GPC vs. poly(ethylene oxide)), powder. Group: Polymers. CAS No. 25086-89-9. Product ID: ethenyl acetate; 1-ethenylpyrrolidin-2-one. Molecular formula: 197.23g/mol. Mole weight: C10H15NO3. CC(=O)OC=C.C=CN1CCCC1=O. InChI=1S/C6H9NO. C4H6O2/c1-2-7-5-3-4-6(7)8; 1-3-6-4(2)5/h2H, 1, 3-5H2; 3H, 1H2, 2H3. FYUWIEKAVLOHSE-UHFFFAOYSA-N. | |
| Poly(dimethylsiloxane-b-ethylene oxide),methyl terminated,mw 3000(80-150 cps) | Poly(dimethylsiloxane-b-ethylene oxide),methyl terminated,mw 3000(80-150 cps). Uses: Designed for use in research and industrial production. Product Category: Polymer/Macromolecule. CAS No. 68937-54-2. Mole weight: 3000. Purity: 0.96. Density: 1.07. Product ID: ACM68937542. Alfa Chemistry ISO 9001:2015 Certified. | |
| Poly(dimethylsiloxane-b-ethylene oxide),methyl terminated,mw 600(20 cps) | Poly(dimethylsiloxane-b-ethylene oxide),methyl terminated,mw 600(20 cps). Uses: Designed for use in research and industrial production. Product Category: Polymer/Macromolecule. CAS No. 68937-54-2. Mole weight: 600. Product ID: ACM68937542-1. Alfa Chemistry ISO 9001:2015 Certified. | |
| Polyethylene oxide,diamine terminated(134cs(50°c)) | Polyethylene oxide,diamine terminated(134cs(50°c)). Uses: Designed for use in research and industrial production. Additional or Alternative Names: POLY(PROPYLENE GLYCOL)-BLOCK-POLY(ETHYLENE GLYCOL)-BLOCK-POLY(PROPYLENE GLYCOL) BIS(2-AMINOPROPYL ETHER);Oxirane,methyl-,polymerwithoxirane,bis(2-aminopropyl)ether;Poly(oxyethylene,oxypropylene)diamine;poly(propyleneglycol-block-peg-block-ppgbis(2-a;POLY(. Product Category: Polymer/Macromolecule. CAS No. 65605-36-9. Mole weight: 2000. Purity: 0.96. Density: 1.08. Product ID: ACM65605369. Alfa Chemistry ISO 9001:2015 Certified. | |
| 2-(2-(2-Ethoxyethoxy) ethoxy)ethanamine | 2-(2-(2-Ethoxyethoxy) ethoxy)ethanamine. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 145373-80-4. Product ID: 2-[2-(2-ethoxyethoxy)ethoxy]ethanamine. Molecular formula: 177.24g/mol. Mole weight: C8H19NO3. CCOCCOCCOCCN. InChI=1S / C8H19NO3 / c1-2-10-5-6-12-8-7-11-4-3-9 / h2-9H2, 1H3. WWJVRDMJNJTOBL-UHFFFAOYSA-N. | |
| 2-[2-(2-Methoxyethoxy)ethoxy]acetic acid | 2-[2-(2-Methoxyethoxy)ethoxy]acetic acid. Uses: This product is suitable for scientific research. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: O-[2-(2-Methoxyethoxy)ethyl]glycolic acid. CAS No. 16024-58-1. Product ID: 2-[2-(2-methoxyethoxy)ethoxy]acetic acid. Molecular formula: 178.18. Mole weight: CH3(OCH2CH2)2OCH2CO2H. COCCOCCOCC(O)=O. 1S/C7H14O5/c1-10-2-3-11-4-5-12-6-7 (8)9/h2-6H2, 1H3, (H, 8, 9). YHBWXWLDOKIVCJ-UHFFFAOYSA-N. Technical grade. | |
| 2-[2-(2-Methoxyethoxy)ethoxy]acetic acid | technical grade. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 2-[2-(2-Methoxyethoxy)ethoxy]ethyl methacrylate | 2-[2-(2-Methoxyethoxy)ethoxy]ethyl methacrylate. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: Methoxytriethyleneglycol methacrylate; Triethylene glycol methyl ether methacrylate. CAS No. 24493-59-2. Product ID: 2-[2-(2-methoxyethoxy)ethoxy]ethyl 2-methylprop-2-enoate. Molecular formula: 232.27g/mol. Mole weight: C11H20O5. CC(=C)C(=O)OCCOCCOCCOC. InChI=1S/C11H20O5/c1-10 (2)11 (12)16-9-8-15-7-6-14-5-4-13-3/h1, 4-9H2, 2-3H3. OBBZSGOPJQSCNY-UHFFFAOYSA-N. 95%. | |
| 2,4,7,9-Tetramethyl-5-decyne-4,7-diol ethoxylate | 2,4,7,9-Tetramethyl-5-decyne-4,7-diol ethoxylate. Uses: Surfactant. reduces surface tension; wetting agent, defoamer, and emulsifier for emulsion polymerization. Group: Self-assembly materials. Alternative Names: 2,4,7,9-tetramethyl-5-decyne-4,7-diol, Acetylenol EL, 2,4,7,9-Tetramethyl-5-decyne-4,7-diol-ethylene oxide adduct. CAS No. 9014-85-1. Pack Sizes: Packaging 100 mL in poly bottle. Product ID: ethane-1,2-diol; 2,4,7,9-tetramethyldec-5-yne-4,7-diol. Molecular formula: 288.42g/mol. Mole weight: (CH3)2CHCH2C (CH3)[ (-OCH2CH2-)mOH]C?CC (CH3)[ (-OCH2CH2-)nOH]CH2CH (CH3)2. OCCO.CC(C)CC(C)(O)C#CC(C)(O)CC(C)C. 1S/C14H26O2.C2H6O2/c1-11(2)9-13(5, 15)7-8-14(6, 16)10-12(3)4;3-1-2-4/h11-12, 15-16H, 9-10H2, 1-6H3;3-4H, 1-2H2. SUHUKEQAOUOUJO-UHFFFAOYSA-N. | |
| 4,7,10,13,16,19,22,25,32,35,38,41,44,47,50,53-Hexadecaoxa-28,29-dithiahexapentacontanedioic acid | ?95%. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester | 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 947601-98-1. Product ID: (2,5-dioxopyrrolidin-1-yl) 3- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [3- (2, 5-dioxopyrrolidin-1-yl) oxy-3-oxopropoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethyldisulfanyl] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoate. Molecular formula: 1109.3g/mol. Mole weight: C46H80N2O24S2. C1CC (= O) N (C1= O) OC (= O) CCOCCO CCOCCOCCOCCOCCOCCOCCSSCCOCCOCCOCCOCC OCCOCCOCCOCCC (= O) ON2C (= O) CCC2= O. InChI= 1S / C46H80N2O24S2 / c49-41-1-2-42 (50) 47 (41) 71-45 (53) 5-7-55-9-11-57-13-15-59-17-19-61-21-2 3-63-25-27-65-29-31-67-33-35-69-37-39 -73-74-40-38-70-36-34-68-32-30-66-28- 26-64-24-22-62-20-18-60-16-14-58-12-1 0-56-8-6-46 (54) 72-48-43 (51) 3-4-44 (48) 52 / h1-40H2. CIAGMHUFXZNZOO-UHFFFAOYSA-N. | |
| 4,7,10,13,16,19,22,25,32,35,38,41,44,47,50,53-Hexadecaoxa-28,29-dithiahexapentacontanedioic acid di-N-succinimidyl ester | ?94% (oligomer purity). Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-COOH | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K 2arm-OH 2arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-NH2 | HCl Salt, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K 2arm-OH 2arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-COOH | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K 3arm-OH 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-NH2 | HCl Salt, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K 3arm-OH 1arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: 3d printing materials poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Acrylate, 4arm-PEG-ACLT. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-COOH | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Glutaric Acid | pentaerythritol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K-Glutaric Acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Glutaric Acid. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Isocyanate | average Mn 10000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG10K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Maleimide | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
Our database is helping our users find suppliers everyday.
